This section hosts guidelines, manuals and toolkits to strengthen public health practice.
The aim of this document is to assist national tuberculosis (TB) programs in developing the strongest possible mechanisms of surveillance for drug resistance in TB, building on more than 25 years of global experience. This starts from periodic surveys of sampled patients, moving towards an ultimate goal of continuous surveillance systems based on routine drug susceptibility testing (DST). This guidance promotes certain standardized criteria for surveillance to ensure that results are comparable within and between countries over time. This document is aimed at national TB programmes and, in particular, the coordination team for surveillance ideally composed of a program manager, a laboratory specialist, a logistician, and an epidemiologist/statistician. Click here to read the report.